TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05948020

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CBT102-A capsule
Description: Orally CBT102-A will be supplied by CommBio Therapeutics. It is an enteric-coated capsule with 1.25×10\^11 live cell. The shelf life is 6 months.~Subjects receive oral dose of 1 capsule CBT102-A (1.25 x 10\^11 live cell) before three meals per day on Day 1 to Day 4; Subjects receive oral dose of 2 capsule CBT102-A (2.5 x 10\^11 live cell) before three meals per day on Day 5 to Day 8; Subjects receive oral dose of 4 capsule CBT102-A (5 x 10\^11 live cell) before three meals per day on Day 9 to Day 12; Subjects receive oral dose of 8 capsule CBT102-A (1 x 10\^12 live cell) before three meals per day on Day 13 to Day 20; All subjects will be observed for 3 days (Day 21\~Day 23) without intervene in hospital and will be followed up weekly for 4 consecutive weeks after discharge（Day 51）.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule
Description: Orally placebo will be supplied by CommBio Therapeutics. It is an enteric-coated capsule with Lactose powder filler. The shelf life is 6 months. The color, condition, smell and other appearances are exactly the same as CBT102-A.~Subjects receive oral dose of 1 capsule placebo before three meals per day on Day 1 to Day 4; Subjects receive oral dose of 2 capsule placebo before three meals per day on Day 5 to Day 8; Subjects receive oral dose of 4 capsule placebo before three meals per day on Day 9 to Day 12; Subjects receive oral dose of 8 capsule placebo before three meals per day on Day 13 to Day 20; All subjects will be observed for 3 days (Day 21\~Day 23) without intervene in hospital and will be followed up weekly for 4 consecutive weeks after discharge（Day 51）.
Study: NCT05628129

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: smartphone application service and phone reminder
Description: smartphone application service and phone reminder for appointments of parents of congenital ectopia lentis patients
Study: NCT05612594

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bexagliflozin 20 mg
Description: 15mg once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matching placebo once daily
Study: NCT04771481

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metoclopramide
Description: Metoclopramide 10 mg + NSS 10 ml intravenous slowly push in 5min before endoscopy 30-120 min

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline 10 mL Injection
Description: Normal saline 10 ml intravenous slowly push in 5min before endoscopy 30-120 min
Study: NCT05549089

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Insignia™ twin brackets
Description: it is metal orthodontic twin brackets with customized base and individual arch-wires for each patient

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Maestro® 3D Ortho Studio software (Discovery, Dentaurum®, Ispringen, Germany)
Description: it is conventional metal orthodontic twin brackets will be customizing the bracket base with adhesive composite, individual arch-wires for each patient and 3D printing indirect bonding tray

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ray set® device (Discovery, Dentaurum®, Ispringen, Germany)
Description: it is conventional metal orthodontic twin brackets will be customizing the bracket base with adhesive composite, individual arch-wires for each patient and double-layer vacuum-formed thermoplastic indirect bonding tray
Study: NCT05818072

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: One biopsy
Description: To do one biopsy at the proximal part of the longest columnar-lined esophagus.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Three biopsy
Description: To do three biopsy at the proximal, middle and distal part of the longest columnar-lined esophagus.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Seattle protocol
Description: To do 4-quadrant biopsy every 1-2 cm at the esophagogastric junction. Seattle protocol has been considered as the gold standard biopsy protocol for patients with suspected Barrett's Esophagus.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endoscopy
Description: The participants will receive meticulous endoscopic examination with narrow-band imaging.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Endoscopy
Description: The participants will receive meticulous endoscopic examination with narrow-band imaging.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopy
Description: The participants will receive meticulous endoscopic examination with narrow-band imaging.
Study: NCT04833790

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Free distribution of ORS
Description: Provides will receive 3 months supply of ORS at the beginning of the study to dispense to their patients. They will be asked to dispense the ORS at the market rate and not to give it away to other providers.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Free distribution of ORS
Description: Provides will receive 3 months supply of ORS at the beginning of the study to dispense to their patients. They will be asked to dispense the ORS at the market rate and not to give it away to other providers.
Study: NCT04008628

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrous Oxide
Description: Inhalation of a 50%/50% nitrous oxide/oxygen mixture (Kalinox®)
Study: NCT04549103

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise program
Description: Baduanjin (BDJ), also known as Eight-Section Brocades, is one of the forms of traditional Chinese Qigong exercises, characterized by symmetrical physical posture, movements, mindfulness, and breathing. Its primary focus is on the release of 'Qi' or internal body energy with the intent of improving health outcomes. BDJ encompasses eight simple movements involving combinations of postures, meditation, slow relaxing movements, and breathing exercises. It is a low intensity exercise, which have been found to improve range of motion, strength and general health. The simplicity and low intensity level is ideal for older adults to practice at home using instructional videos.
Study: NCT06214351

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Use of mobile midwifery application
Description: Pregnant women in the experimental group will have a mobile midwifery application installed on their smartphones. The pregnant woman will be able to reach the research midwife 24/7. With the informative content and algorithm mechanism in the application, she will be able to provide individual care and detect early signs of danger, enabling her to seek medical attention.
Study: NCT04833790

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with ORS preference
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who requests ORS to treat their child's diarrhea.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with ORS preference
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who requests ORS to treat their child's diarrhea.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with Antibiotic preference
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who requests Antibiotics to treat their child's diarrhea.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with Antibiotic preference
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who requests Antibiotics to treat their child's diarrhea.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with no preference
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who does not request anything specific to treat their child's diarrhea.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with no preference
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who does not request anything specific to treat their child's diarrhea.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with no preference + no financial incentive
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who does not request anything specific to treat their child's diarrhea. In addition they will inform the provider that they are not going to purchase anything from the provider because they have an uncle with a drug shop where they can get a discount.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with no preference + no financial incentive
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who does not request anything specific to treat their child's diarrhea. In addition they will inform the provider that they are not going to purchase anything from the provider because they have an uncle with a drug shop where they can get a discount.
Study: NCT04959591

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intravenous acetaminophen
Description: experimental(pre): administration of IV acetaminophen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intravenous acetaminophen
Description: experimental(post): administration of IV acetaminophen

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo comparator: administration of normal saline
Study: NCT04987346

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walking on an instrumented treadmill
Description: Participants will be asked to walk at different gait velocities for 1 minute. The treadmill speed will be increased incrementally at 0.1m/s intervals until just before running.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walking on an instrumented treadmill while dual-tasking
Description: Participants aged between 6 and 17 years will be asked to walk at comfortable walking speed while playing either a cognitive (Stroop Color and Word Test) or motor (requiring arm swing) game.
Study: NCT06077318

Intervention type: OTHER
Intervention: Keyhole repair
Description: The keyhole technique involves placing a mesh with a slit in the central hole around the intestinal ring, allowing facilitating the passage of the intestine through the central slit.

Intervention type: OTHER
Intervention: Sugarbaker repair
Description: The modified Sugarbaker technique uses a mesh to place a patch on the lateralized intestine, effectively preventing herniation of abdominal contents through the stoma.
Study: NCT05473390

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: functional electrical stimulation
Description: functional electrical stimulation on back muscles

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: functional electrical stimulation
Description: functional electrical stimulation on back muscles

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: kinesotaping
Description: no intervention
Study: NCT05776498

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: immediate implant placement with particulate bone graft using the dual zone technique.
Description: Tooth extraction and immediate implant placement as mentioned, then particulate bone graft will be packed in the gap between the implant and the buccal plate of bone and the tissue (dual zone), then will be covered by a customized healing abutment.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: immediate implant placement with connective tissue grafting
Description: Tooth extraction and immediate implant placement as mentioned. Connective tissue grafts will be harvested from the hard palate and placed at the implant sites in a supraperiosteal partial dissection pouch prepared at the buccal aspect without using vertical incisions and without flap elevation. Sutures will be used to stabilize the graft in its desired place. Followed by customized healing abutment.
Study: NCT05746949

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: oxygenization techniques
Description: to compare the effects of high-flow nasal oxygen and jet ventilation on oxygenation in patients who will receive general anesthesia for endolaryngeal surgery.
Study: NCT05851066

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VSA003
Description: sequential dosing, SC, single dose: 50 mg, 100 mg, 200 mg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% NaCl
Description: placebo
Study: NCT05370313

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Market Price Condition (control)
Description: Nicotine/tobacco products available in the Experimental Tobacco Marketplace at market price. Cigarette taxes increased across trials at the same magnitudes used in the tax conditions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Market Price Condition (control)
Description: Nicotine/tobacco products available in the Experimental Tobacco Marketplace at market price. Cigarette taxes increased across trials at the same magnitudes used in the tax conditions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Market Price Condition (control)
Description: Nicotine/tobacco products available in the Experimental Tobacco Marketplace at market price. Cigarette taxes increased across trials at the same magnitudes used in the tax conditions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Market Price Condition (control)
Description: Nicotine/tobacco products available in the Experimental Tobacco Marketplace at market price. Cigarette taxes increased across trials at the same magnitudes used in the tax conditions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tobacco Parity Tax Condition
Description: Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, all tobacco products are placed in the high-tax tier while products that do not contain tobacco (e.g., herbal cigarettes and nicotine-free ENDS) are placed in the medium-tax tier. Nicotine Replacement Therapy products are placed in the no-tax tier.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nicotine-Content Tax Condition
Description: Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, products with greater than 3 mg nicotine per single unit are placed in the high-tax tier, products with 0.6-3.0 mg/unit in the medium-tax tier, and those with 0.5 mg/unit or less in the no-tax tier.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Harm-Reduction Tax Condition
Description: Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, all combustible products with high abuse liability are placed in the high-tax tier. All non-combustible products or combustible products with low abuse liability are placed in the medium-tax tier. Nicotine Replacement Therapy products are placed in the no-tax tier.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified Risk Tobacco Product (MRTP) Tax Condition
Description: Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, all non-MRTP tobacco products are placed in the high-tax tier, MRTPs are placed in the medium-tax tier, and Nicotine Replacement Therapy products are placed in the no-tax tier.
Study: NCT06375902

Intervention type: BEHAVIORAL
Intervention: PragmaCom
Description: Cognitive behavioral intervention targeting the ability to understand metaphors
Study: NCT06368583

Intervention type: OTHER
Intervention: Interview
Description: Patients will be interviewed by the research team to learn about their experience of vaginal delivery with neuraxial analgesia
Study: NCT06262230

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Inclusive Companionship Intervention
Description: After prior intervention, professionals will conduct a lecture for ordinary children, which includes basic knowledge of ASD and communication skills with ASD children. These ordinary children will be paired with ASD children then. The entire intervention including 12 sessions will last for 3 months. Researchers will prepare a series of themes that the ASD children could choose, and the ordinary children need to ask their paired ASD children what activities they want to choose before each session. Then, they will carry out this entertainment online together through Tencent WeMeet. A researcher will supervise online at the same time and record the communication through instant video. The Researcher will turn off the video and sound throughout the process and will not intervene in the conversation between the ASD children and ordinary children except for special circumstances.
Study: NCT05037734

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Persona Partial Knee System
Description: Unicompartmental Knee Replacement

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Persona Partial Knee System
Description: Unicompartmental Knee Replacement
Study: NCT06091267

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Decitabine
Description: The subjects will receive decitabine 20 mg/m\^2 IV daily × 5 days in 28-day cycles.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IV Decitabine
Description: The subjects will receive decitabine 20 mg/m\^2 IV daily × 5 days in 28-day cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine and cedazuridine
Description: subjects will receive treatment with ASTX727, 1 tablet/day for 5 consecutive days, in 28-day cycles.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Decitabine and cedazuridine
Description: subjects will receive treatment with ASTX727, 1 tablet/day for 5 consecutive days, in 28-day cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: only Decitabine and cedazuridine
Description: subjects will receive treatment with ASTX727, 1 tablet/day for 5 consecutive days, in 28-day cycles, until disease progression, unacceptable toxicity, or the subject/investigator decides that the subject should discontinue treatment or withdraw from the trial.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: only Decitabine and cedazuridine
Description: subjects will receive treatment with ASTX727, 1 tablet/day for 5 consecutive days, in 28-day cycles, until disease progression, unacceptable toxicity, or the subject/investigator decides that the subject should discontinue treatment or withdraw from the trial.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: only Decitabine and cedazuridine
Description: subjects will receive treatment with ASTX727, 1 tablet/day for 5 consecutive days, in 28-day cycles, until disease progression, unacceptable toxicity, or the subject/investigator decides that the subject should discontinue treatment or withdraw from the trial.
Study: NCT05698797

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hip strengthening exercises
Description: Hip abductor and external rotator strengthening exercises were performed for 4 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Proprioceptive training
Description: Proprioceptive training consisted of eight exercises was performed for 4 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy
Description: Conventional physical therapy included interferential therapy and two types of knee-strengthening exercises.
Study: NCT05464810

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: Given PO

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Letrozole
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simvastatin
Description: Given PO
Study: NCT05485194

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Reducing dimensional changes following tooth extraction
Description: Use of a titanium bone screw for ridge preservation following tooth extraction

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reducing dimensional changes following tooth extraction
Description: Use of a titanium bone screw for ridge preservation following tooth extraction
Study: NCT06457373

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Demineralized Dentin Allograft
Description: 20 sockets are randomly allocated to receive the Demineralized Dentin Allograft (split-mouth study)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Demineralized Dentin Autograft
Description: 20 sockets are randomly allocated to receive the Demineralized Dentin Autograft (split-mouth study)
Study: NCT00961558

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Varicocelectomy
Description: Varicocelectomy
Study: NCT06127511

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food (peanut)
Description: After the recruitment, the participants will follow a peanut-free diet for two weeks.
Study: NCT05352867

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 (LVRNA009) 50μg group
Description: 50μg/person

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 (LVRNA009) 100μg group
Description: 100μg/person

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.5ml/person
Study: NCT06395740

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enteral nutrtion
Description: enteral nutrition via nasogastric tube.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TPN
Description: of NPO strategy except for medications to be given via nasogastric tube till 14 days from day of stroke with fulfilment of nutrition requirement by parenteral route
Study: NCT05778357

Intervention type: OTHER
Intervention: Group1
Description: 75 healthy infants were included. Neuromotor development was evaluated with the Denver II Developmental Screening Test and Alberta Infant motor scale.